Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Natus Medical acquires Babybe, terms not disclosed » 08:07
11/23/20
11/23
08:07
11/23/20
08:07
NTUS

Natus Medical

$20.43 /

+0.1 (+0.49%)

Natus Medical announced…

Natus Medical announced the acquisition of Babybe GmbH and its patented remote mother to baby communication technology. The Babybe technology will add to Natus's market leading Newborn Care portfolio of products. Babybe offers an innovative new way to remotely connect a mother and her baby in the neonatal intensive care unit. With this technology, mother and baby are connected in real time through heartbeat, breathing and vocal sounds using an active mattress system. Clinical studies are currently underway to assess how the mother and baby connection impacts weight gain, apnea and neuro-development in premature newborns who are isolated in the NICU. Natus expects the Babybe product to be available in commercial quantities in early 2022.

Over a quarter ago
Hot Stocks
Natus Medical partners with Holberg EEG to advance epilepsy diagnosis » 09:31
05/12/20
05/12
09:31
05/12/20
09:31
NTUS

Natus Medical

$22.61 /

-0.39 (-1.70%)

Natus Medical announced a…

Natus Medical announced a partnership with Holberg EEG AS. The partnership will advance the development and distribution of an AutoSCORE algorithm to automate Electroencephalography classifications and improve reporting efficiency. Holberg EEG has developed and commercialized SCORE EEG, a reporting and database software that builds on the new international consensus for describing EEG examinations and replaces free text reporting. The new partnership will advance the next steps to develop AutoSCORE, which will provide decision support to reduce EEG reporting variability, improve quality, and reduce time and cost for users. AutoSCORE has the potential to improve clinical outcome and value of care for the millions suffering from epilepsy.

ShowHide Related Items >><<
NTUS Natus Medical
$22.61 /

-0.39 (-1.70%)

NTUS Natus Medical
$22.61 /

-0.39 (-1.70%)

Hot Stocks
Natus Medical appoints Ilan Daskal to board of directors » 08:21
03/20/20
03/20
08:21
03/20/20
08:21
NTUS

Natus Medical

$19.43 /

-0.34 (-1.72%)

, BIO

Bio-Rad

$344.38 /

-12.885 (-3.61%)

Natus Medical (NTUS)…

Natus Medical (NTUS) announced the appointment of Ilan Daskal, current CFO & EVP of Bio-RAD Laboratories (BIO), to its board of directors and audit committee effective March 19, 2020. The Company will also nominate Daskal at its 2020 Annual Meeting of Stockholders. Kenneth Ludlum has advised the board that he will not stand for re-election at the 2020 Annual Meeting of Stockholders. Following Mr. Ludlum's retirement, the Natus board will be composed of seven directors.

ShowHide Related Items >><<
NTUS Natus Medical
$19.43 /

-0.34 (-1.72%)

BIO Bio-Rad
$344.38 /

-12.885 (-3.61%)

03/03/20 Citi
Bio-Rad margin expansion story in early innings, says Citi
01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Bio-Rad initiated with an Overweight at Wells Fargo
01/06/20 Citi
Citi calls Bio-Rad, Thermo Fisher top picks in Tools industry
Earnings
Natus Medical updates Q4 earnings results, no change to non-GAAP EPS » 16:27
03/02/20
03/02
16:27
03/02/20
16:27
NTUS

Natus Medical

$27.72 /

+0.87 (+3.24%)

The adjustments resulted…

The adjustments resulted in a GAAP net income of $3.0M for Q4, compared to $3.2M previously reported, or 9c per diluted share, compared to 10c previously reported, and a non-GAAP net income of $15.6M, compared to $15.4M previously reported, or 46c per diluted share, which remained the same as previously reported.

Earnings
Natus Medical updates Q4 earnings results, no change to non-GAAP earnings » 16:25
03/02/20
03/02
16:25
03/02/20
16:25
NTUS

Natus Medical

$27.72 /

+0.87 (+3.24%)

The adjustments resulted…

The adjustments resulted in a GAAP net income of $3.0M for Q4, compared to $3.2M previously reported, or 9c per diluted share, compared to 10c previously reported, and a non-GAAP net income of $15.6M, compared to $15.4M previously reported, or 46c per diluted share, which remained the same as previously reported.

Earnings
Natus Medical sees FY20 EPS $1.45-$1.55, consensus $1.70  16:30
02/06/20
02/06
16:30
02/06/20
16:30
NTUS

Natus Medical

$33.78 /

+0.14 (+0.42%)

 
ShowHide Related Items >><<
Earnings
Natus Medical sees Q1 EPS 19c-25c, consensus 27c » 16:29
02/06/20
02/06
16:29
02/06/20
16:29
NTUS

Natus Medical

$33.78 /

+0.14 (+0.42%)

Sees Q1 revenue…

Sees Q1 revenue $113M-$117M, consensus $116M.

ShowHide Related Items >><<
Earnings
Natus Medical reports Q4 EPS 46c, consensus 47c » 16:27
02/06/20
02/06
16:27
02/06/20
16:27
NTUS

Natus Medical

$33.78 /

+0.14 (+0.42%)

Reports Q4 revenue…

Reports Q4 revenue $131.8M, consensus $130M. "Our Neuro business showed significant growth during the quarter with a 14.5% increase in year over year after adjusting for the divestiture of GND, driven by new cybersecurity features and Windows(R) 10 upgrades in our EEG products as well as strength in our sleep and neurosurgery business. Overall, we achieved organic revenue growth of 1% after adjusting for our divestitures. Our non-GAAP gross profit margins improved 390 basis points during the quarter. Strong operating cash flows of $12.7 million and another $15 million in debt reduction put Natus in a net cash position at the end of the year," said Jonathan Kennedy, President and Chief Executive Officer of Natus. "Both the Newborn Care and the Hearing & Balance businesses declined during the quarter. However, we expect them to return to growth in the first quarter of 2020 as we return key products to the market."

ShowHide Related Items >><<
Hot Stocks
iRadimed EVP of worldwide sales and marketing Brent Johnson to retire » 07:27
01/07/20
01/07
07:27
01/07/20
07:27
IRMD

iRadimed

$25.18 /

+0.71 (+2.90%)

, NTUS

Natus Medical

$32.86 /

+0.27 (+0.83%)

IRADIMED CORPORATION…

IRADIMED CORPORATION (IRMD) announced the retirement of Brent Johnson, EVP of Worldwide Sales and Marketing, effective April 10, 2020 after leading the company's commercial efforts since 2012. IRADIMED appointed MaryBeth Smith as VP of Worldwide Sales, succeeding Johnson, effective January 20, 2020. Smith will report to Leslie McDonnell, President and CEO. Prior to her appointment at IRADIMED, Smith spent more than 20 years at Natus Medical (NTUS), most recently as the VP of Sales and Sales Operations for newborn care products.

ShowHide Related Items >><<
Hot Stocks
Natus Medical finalizes transition of Peloton business to Pediatrix Medical » 16:11
01/02/20
01/02
16:11
01/02/20
16:11
NTUS

Natus Medical

$32.64 /

-0.29 (-0.88%)

, MD

Mednax

$27.44 /

-0.37 (-1.33%)

Natus Medical…

Natus Medical Incorporated (NTUS) announced that effective December 31, 2019 the company has finalized and executed the previously announced transition of the Peloton hearing screening services business to Pediatrix Medical Group. Pediatrix Medical Group, a MEDNAX, Inc. (MD) company, will manage all newborn hearing screening services for Peloton hospitals while Natus will provide its best-in-class ALGO screeners and supplies to Pediatrix to support its entire hearing screening business. Installation of ALGO screeners at the Pediatrix hospitals is expected to be completed during 2020.

ShowHide Related Items >><<
NTUS Natus Medical
$32.64 /

-0.29 (-0.88%)

MD Mednax
$27.44 /

-0.37 (-1.33%)

12/20/19 JPMorgan
JPMorgan reverses stance on Managed Care, turns more bullish into 2020
12/16/19 Credit Suisse
Mednax could be LBO target in $35-$36 per share range, says Credit Suisse
12/12/19 Stifel
Mednax upgraded to Buy from Hold at Stifel
09/06/19 BofA
Mednax downgraded to Underperform from Neutral at BofA/Merrill

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.